Granules India plans ₹2,000 crore capex, targets $100M peptide revenue

Granules India plans ₹2,000 crore organic capex to scale peptide production. The company aims to generate $100 million in revenue from its peptide segment. This strategic push aligns with expanding global demand for complex generics. Management emphasized long-term margin expansion through vertical integration.

📊 STOCKS: $GRANULES | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #Capex